Timing of Sodium Intake and Nocturnal Sodium Excretion and Blood Pressure in Obese African Americans
NCT04021355
Body Weight, Cardiovascular Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT Number: NCT02895282
The main objective is to investigate chronobiological aspects of childhood obesity studying the potential relationship between meal patterns and circadian rhythmicity in a cross-sectional sample of obese, overweight and normal weight children/adolescent.
Looking for future studies?
Notify Me8 year–12 year
All sexes
Observational
Chronobiology laboratory, Department of Physiology, Murcia, Spain
Childhood obesity has more than doubled in children and tripled in adolescents in the past 30 y. As consequence, increasingly children and adolescents suffer from elevated blood pressure, impaired glucose tolerance, hyperinsulinemia, dyslipidemia. Obesity has a multifactorial etiology since there are potentially numerous contributors to its development and progression. Chronobiology, the science that studies periodic (cyclic) changes in living organisms, has been recently proposed as a new and promising topic to investigate. Alterations of circadian (24 h oscillations) system may contribute to obesity and its complications development such as high blood pressure, insulin resistance, altered fasting lipid profile. Conversely, in a vicious manner, obesity has been regarded as a fault in the circadian system explainable by the association with imbalances and fluctuations of hormones/genes expressions rhythms under the influence of body weight changes.
Thus, the study will examine changes in circadian rhythmicity over a week period. The primary end point will be to evaluate differences between obese/overweight and non-obese children in chronotypes and the responses of these parameters to meal patterns. In particular, non-invasive measures that are well-established determinants of chronotypes will form the core endpoints for the study. Well designed and age-appropriate questionnaires will provide further information in order to study correlations with eating, sleeping and sedentary/active behaviors.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: At baseline
A key index for relating weight to height. BMI is a person's weight in kilograms (kg) divided by his or her height in meters squared.
Time frame: At baseline
To assess chronotype with a questionnaire that establishes an algorithm which optimises chronotype assessment by incorporating the information on timing of sleep and wakefulness for both work and free days. The timing and duration of sleep are generally independent. However, when the two are analysed separately for work and free days, sleep duration strongly depends on chronotype. In addition, chronotype is both age- and sex-dependent.
Time frame: At baseline
Wrist temperature wireless recording is considered a reliable procedure to evaluate circadian rhythmicity, and an index to establish and follow the effects of chronotherapy in normal living subjects.
Time frame: At baseline
Rest-activity rhythm as assessed using a acceleration data logger UA-004-64 (Onset Computer, Bourne, MA, USA) placed on the non-dominant arm by means of a sports band, with its x axis parallel to the humerus bone. The sensor is programmed to record data every 30 s.
Time frame: At baseline
24hs record of sleep will be completed during the 7 days of the experiment. Children are instructed to keep a sleep and food diary designed by the University of Murcia Chronobiology Laboratory. The following data will be obtained for every subject on a daily basis: time to bed, time of lights off, nocturnal awakenings lasting more than 10 minutes, sleep offset, the time the participant arose.
Time frame: At baseline
Saliva for cortisol measurements is obtained before breakfast (09:00 h), lunch time (14:00 h), and bedtime (23:00 h) the 6th the 7th day of the experimental week using the Salivette system. Cortisol is measured with radioimmunoassay.
Time frame: At baseline
Samples for the measurement of salivary melatonin are obtained before lunch (14:00 h) and at night (1:00 h) the 6th and 7th day of the experimental week.
Time frame: At baseline
During the week of the experiment. Data will be obtained for every subject on a daily basis and they will record the variety of foods that they eat with the portion size.
Time frame: At baseline
During the week of the experiment with a software designed for this purpose.
Time frame: At baseline
from the 7 days dietary record, with a software designed for this purpose.
Time frame: At baseline
from the 7 days dietary record, with a software designed for this purpose.
Time frame: At baseline
from the 7 days dietary record, with a software designed for this purpose.
Time frame: Through study completion
from the 7 days dietary record, with a software designed for this purpose.
Time frame: At baseline
From the 7 days dietary record, with a software designed for this purpose.
Time frame: At baseline
Children will be instructed to keep a food diary. Data will be obtained for every subject on a daily basis and they will record the time of the three main meals (breakfast, lunch, and dinner).
Time frame: At baseline
During the week of the experiment with a light detector device in the neck of the children.
Time frame: At baseline
Saliva will be collected to further extraction of DNA the 7th day of the experimental week.
Time frame: At baseline
Saliva Collection Method is the SalivaBio Oral Swab the 7th day of the experimental week.
Universidad de Murcia
Other
Chronobiology and Childhood Obesity in a Mediterranean Spanish Population (ONTIME-JR: Obesity, Nutrigenomics, Timing, Mediterranean, Junior)
Acronym: ONTIME-JR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04021355
Body Weight, Cardiovascular Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT03934177
Body Weight, Chronobiology Disorders
Lincoln, Nebraska, United States
View Trial DetailsNCT02674230
Aging, Body Weight
Taoyuan, Taiwan
View Trial DetailsNCT03388788
Body Weight, Cardiovascular Risk Factor
Portland, Oregon, United States
View Trial Details